Clinical trial
Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human…
NCT00139828 · Prothya Biosolutions, Industry · Completed
Key facts
| NCT number | NCT00139828 |
|---|---|
| Title | Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) |
| Official title | Post Marketing Study in Haemophilia B Patients Using Nonafact® 100 IU/ml Powder and Solvent for Solution for Injection(Human Coagulation Factor IX)(Human Plasma Derived Factor IX Product, Freeze Dried) |
| Lead sponsor | Prothya Biosolutions, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hemophilia B |
| Intervention type | Drug |
| Interventions | human coagulation Factor IX |
| Enrollment | 12 |
| Start date | May 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Aug 31, 2005 |
| Last update posted | Aug 30, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: